Search results
Genentech's legacy and future aspirations are built on the belief that the boundaries of science are meant to be broken and that we can solve some of the hardest biomedical challenges plaguing humankind. Breakthrough science. One moment, one day, one person at a time.
- Advancing Inclusive Research
Advancing Inclusive Research ® (AIR) is an innovative...
- Patient Financial Support
If you need help understanding your health insurance...
- Clinical Trial Information
In rare circumstances, Genentech may provide patients with...
- Our Pipeline
Rigorous and groundbreaking science has always been at the...
- Our Medicines
You may also report side effects to Genentech at (888)...
- Featured Topics
Genentech Patient Foundation; Clinical Trials; Patient...
- Hematology
Hematology. Learn about the field, the research, and the...
- Giving
We also support the Genentech Foundation, a U.S.-based,...
- Advancing Inclusive Research
Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for more than 45 years. Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases.
Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California. It became an independent subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche. Historically, the company is regarded as the world's first biotechnology company.
Visit Us. Following our March 2009 merger with Roche, Genentech's South San Francisco campus became the headquarters for Roche pharmaceutical operations in the United States. All of Genentech's U.S. sites are united by our goal of meeting the needs of patients.
WHY GENENTECH. We’re passionate about delivering on Our Promise to improve the lives of patients and create healthier communities for all. We foster a culture of inclusivity, integrity and creativity while boldly pursuing answers to the world’s most complex health challenges and transforming society.
Genentech | 749,830 followers on LinkedIn. About Genentech We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions.
Genentech is a leading biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Its transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.